+30.4%
GSK vs WAB
+48.2%
-17.7%
-18.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | WAB | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.9% | +0.7% | -2.6% | -2.1% |
| 7D | -1.8% | -3.2% | +1.4% | -1.0% |
| 30D | -2.2% | -4.4% | +2.3% | -1.1% |
| 3M | -1.8% | +7.9% | -9.7% | -4.7% |
| 6M | -10.6% | +8.7% | -19.3% | -13.8% |
| YTD | +4.4% | +33.0% | -28.6% | -5.1% |
| 1Y | +30.4% | +46.7% | -16.2% | +14.9% |
| All | +30.4% | +48.2% | -17.7% | +14.9% |
Cumulative growth
Daily Returns
Daily percentage return beside WAB.
Daily Out/Under-Performance
Portfolio return minus WAB return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × WAB return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded WAB wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling